HRP20020917A2 - Sulfonamide derivatives - Google Patents
Sulfonamide derivatives Download PDFInfo
- Publication number
- HRP20020917A2 HRP20020917A2 HR20020917A HRP20020917A HRP20020917A2 HR P20020917 A2 HRP20020917 A2 HR P20020917A2 HR 20020917 A HR20020917 A HR 20020917A HR P20020917 A HRP20020917 A HR P20020917A HR P20020917 A2 HRP20020917 A2 HR P20020917A2
- Authority
- HR
- Croatia
- Prior art keywords
- image
- compound
- treatment
- formula
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20582200P | 2000-05-19 | 2000-05-19 | |
| PCT/US2001/011746 WO2001090056A1 (fr) | 2000-05-19 | 2001-05-04 | Derives de sulfonamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20020917A2 true HRP20020917A2 (en) | 2004-02-29 |
Family
ID=22763775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20020917A HRP20020917A2 (en) | 2000-05-19 | 2001-05-04 | Sulfonamide derivatives |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6720357B2 (fr) |
| EP (1) | EP1296944A1 (fr) |
| JP (1) | JP2003534315A (fr) |
| KR (1) | KR20030007643A (fr) |
| CN (1) | CN1429206A (fr) |
| AR (1) | AR028590A1 (fr) |
| AU (1) | AU2001262936A1 (fr) |
| BR (1) | BR0110871A (fr) |
| CA (1) | CA2409829A1 (fr) |
| CZ (1) | CZ20023796A3 (fr) |
| DZ (1) | DZ3344A1 (fr) |
| EA (1) | EA004868B1 (fr) |
| EC (1) | ECSP014079A (fr) |
| HR (1) | HRP20020917A2 (fr) |
| HU (1) | HUP0302291A3 (fr) |
| IL (1) | IL152154A0 (fr) |
| MX (1) | MXPA02010021A (fr) |
| NO (1) | NO20025533L (fr) |
| NZ (1) | NZ521620A (fr) |
| PE (1) | PE20011260A1 (fr) |
| PL (1) | PL358184A1 (fr) |
| SK (1) | SK16322002A3 (fr) |
| SV (1) | SV2002000458A (fr) |
| WO (1) | WO2001090056A1 (fr) |
| ZA (1) | ZA200208746B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA59384C2 (uk) * | 1996-12-20 | 2003-09-15 | Пфайзер, Інк. | Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі |
| GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| US20040235957A1 (en) * | 2001-10-12 | 2004-11-25 | David Bleakman | Use of sulfonamide derivatives as pharmaceuticals compounds |
| WO2005013961A1 (fr) * | 2003-07-17 | 2005-02-17 | Eli Lilly And Company | Polytherapie pour le traitement de troubles cognitifs ou de psychoses |
| JP2007521322A (ja) * | 2003-09-18 | 2007-08-02 | メルク エンド カムパニー インコーポレーテッド | 置換スルホンアミド類 |
| AU2010264095B2 (en) | 2009-06-26 | 2013-07-11 | Biogen Ma Inc. | Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof |
| KR101569842B1 (ko) | 2009-09-30 | 2015-11-17 | 삼성전자 주식회사 | 텔레비전용 전원공급유닛 및 이를 포함하는 텔레비전 |
| US20130058915A1 (en) | 2010-03-02 | 2013-03-07 | Children's Medica Center Corporation | Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
| EP3311842A1 (fr) | 2013-06-13 | 2018-04-25 | VeroScience LLC | Compositions et procédés de traitement des troubles métaboliques |
| EP3436021B1 (fr) | 2016-03-29 | 2026-07-29 | RespireRx Pharmaceuticals, Inc. | Compositions comprenant des ampakines a faible impact pour traiter des troubles de déficit de l'attention |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| AU5239999A (en) | 1998-07-31 | 2000-02-21 | Eli Lilly And Company | Heterocyclyl sulphonamide derivatives |
| PE20000942A1 (es) | 1998-07-31 | 2000-09-28 | Lilly Co Eli | Derivados de amida, carbamato y urea |
| PE20000943A1 (es) | 1998-07-31 | 2000-09-28 | Lilly Co Eli | Derivados de sulfonamida |
| US6525099B1 (en) * | 1998-07-31 | 2003-02-25 | Eli Lilly And Company | N-substituted sulfonamide derivatives |
-
2001
- 2001-05-04 WO PCT/US2001/011746 patent/WO2001090056A1/fr not_active Ceased
- 2001-05-04 HU HU0302291A patent/HUP0302291A3/hu unknown
- 2001-05-04 NZ NZ521620A patent/NZ521620A/en unknown
- 2001-05-04 MX MXPA02010021A patent/MXPA02010021A/es unknown
- 2001-05-04 EP EP01937173A patent/EP1296944A1/fr not_active Withdrawn
- 2001-05-04 SK SK1632-2002A patent/SK16322002A3/sk unknown
- 2001-05-04 KR KR1020027015542A patent/KR20030007643A/ko not_active Withdrawn
- 2001-05-04 EA EA200201232A patent/EA004868B1/ru not_active IP Right Cessation
- 2001-05-04 CA CA002409829A patent/CA2409829A1/fr not_active Abandoned
- 2001-05-04 JP JP2001586246A patent/JP2003534315A/ja not_active Withdrawn
- 2001-05-04 AU AU2001262936A patent/AU2001262936A1/en not_active Abandoned
- 2001-05-04 HR HR20020917A patent/HRP20020917A2/hr not_active Application Discontinuation
- 2001-05-04 BR BR0110871-9A patent/BR0110871A/pt not_active IP Right Cessation
- 2001-05-04 US US10/258,054 patent/US6720357B2/en not_active Expired - Fee Related
- 2001-05-04 IL IL15215401A patent/IL152154A0/xx unknown
- 2001-05-04 CN CN01809668A patent/CN1429206A/zh active Pending
- 2001-05-04 DZ DZ013344A patent/DZ3344A1/fr active
- 2001-05-04 PL PL01358184A patent/PL358184A1/xx not_active Application Discontinuation
- 2001-05-04 CZ CZ20023796A patent/CZ20023796A3/cs unknown
- 2001-05-18 EC EC2001004079A patent/ECSP014079A/es unknown
- 2001-05-18 AR ARP010102376A patent/AR028590A1/es unknown
- 2001-05-18 PE PE2001000452A patent/PE20011260A1/es not_active Application Discontinuation
- 2001-05-18 SV SV2001000458A patent/SV2002000458A/es not_active Application Discontinuation
-
2002
- 2002-10-29 ZA ZA200208746A patent/ZA200208746B/en unknown
- 2002-11-18 NO NO20025533A patent/NO20025533L/no not_active Application Discontinuation
-
2003
- 2003-12-24 US US10/746,164 patent/US6803484B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001262936A1 (en) | 2001-12-03 |
| WO2001090056A1 (fr) | 2001-11-29 |
| DZ3344A1 (fr) | 2001-11-29 |
| NO20025533D0 (no) | 2002-11-18 |
| EA004868B1 (ru) | 2004-08-26 |
| US6803484B2 (en) | 2004-10-12 |
| JP2003534315A (ja) | 2003-11-18 |
| PL358184A1 (en) | 2004-08-09 |
| ZA200208746B (en) | 2004-02-10 |
| HUP0302291A2 (hu) | 2003-11-28 |
| SK16322002A3 (sk) | 2003-05-02 |
| AR028590A1 (es) | 2003-05-14 |
| US20040143020A1 (en) | 2004-07-22 |
| PE20011260A1 (es) | 2001-12-11 |
| CA2409829A1 (fr) | 2001-11-29 |
| ECSP014079A (es) | 2002-02-25 |
| US6720357B2 (en) | 2004-04-13 |
| EP1296944A1 (fr) | 2003-04-02 |
| CZ20023796A3 (cs) | 2003-04-16 |
| CN1429206A (zh) | 2003-07-09 |
| NO20025533L (no) | 2003-01-20 |
| MXPA02010021A (es) | 2003-02-12 |
| EA200201232A1 (ru) | 2003-04-24 |
| IL152154A0 (en) | 2003-05-29 |
| KR20030007643A (ko) | 2003-01-23 |
| HUP0302291A3 (en) | 2006-11-28 |
| US20030233015A1 (en) | 2003-12-18 |
| SV2002000458A (es) | 2002-10-24 |
| BR0110871A (pt) | 2003-02-11 |
| NZ521620A (en) | 2004-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1246797B1 (fr) | Derives de sulfonamide de cyclopentyle | |
| US6803484B2 (en) | Sulfonamide derivatives | |
| WO2000006158A1 (fr) | Derives de sulfamide heterocyclyles | |
| US20030225163A1 (en) | Sulfonamide derivatives | |
| US20040157842A1 (en) | Sulphonamide derivatives | |
| US6639107B1 (en) | Cyclopentyl sulfonamide derivatives | |
| WO2002018329A1 (fr) | Derives de sulfonamide acetylenique | |
| US20040235957A1 (en) | Use of sulfonamide derivatives as pharmaceuticals compounds | |
| WO2000006149A1 (fr) | Sulfamides | |
| WO2002098846A1 (fr) | Derives de sulfonamide | |
| HK1027550A (en) | Sulphonamide derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| OBST | Application withdrawn |